Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

NCT02106988 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

RADIATION: Radiation Therapy
DRUG: Dexamethasone
DRUG: Etoposide phosphate
DRUG: Ifosfamide
DRUG: Mesna
DRUG: Carboplatin

Sponsor

M.D. Anderson Cancer Center